Kabra Drugs Ltd. : Cash Flow Statement
Industry
Phar
BSE Code
524322
Face Value
10.00
Chairman
NSE Code
KABRADG
Market Lot
1
Group
Not Applicable
ISIN No
INE323K01017
Book Closure
30/09/2024
You can view Cashflow Statement.
Particulars
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Months
12
12
12
12
12
Source Of Info (AR = Annual Report, PR = Press Release)
AR
AR
AR
AR
AR
FaceValue
10.00
10.00
10.00
10.00
10.00
Net Profit/Loss Before Extraordinary Items And Tax
-1.09
-0.74
-0.34
-0.19
-0.18
Net CashFlow From Operating Activities
-4.71
-0.21
-0.35
-0.13
-0.25
Net Cash Used In Investing Activities
-0.05
0.00
0.00
0.00
0.00
Net Cash Used From Financing Activities
23.39
2.88
0.36
0.13
0.25
Net Inc/Dec In Cash And Cash Equivalents
18.63
2.67
0.00
-0.01
0.00
Cash And Cash Equivalents Begin of Year
2.67
0.00
0.00
0.01
0.01
Cash And Cash Equivalents End Of Year
21.30
2.67
0.00
0.00
0.01
Company Info
Type first few letters
*